The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
Premium- The Jefferies Group downgraded Isis Pharmaceuticals (NASDAQ:ISIS) this morning from a Buy rating to an Underperform, causing shares to follow suit by 10%. Zack’s, meanwhile, … Continue Reading
Read now- Shares of Amarin Corporation (NASDAQ:AMRN) moved higher on Thursday after a webpage suggesting ‘Vascepa’ as the brand name for AMR101 – a prescription fish oil … Continue Reading
Read now- Novartis (NYSE:NVS) provided its Q2 earnings report this morning and although revenue fell slightly from $14.92B last year to $14.3B, net profits mirrored last year’s … Continue Reading
Read now- With most global drug companies missing estimates on currency and international economic woes, Baxter (NYSE: BAX) put up an impressive quarter, beating Wall Street’s top … Continue Reading
Read now- Data presented at the International Spine Intervention Society (ISIS) 20th Annual Scientific Meeting demonstrated that Boston Scientific’s (NYSE: BSX) Infinionâ„¢ 16 Percutaneous Lead effectively relieved … Continue Reading
Read now- The world’s largest insulin producer, Novo Nordisk (NYSE:NVO), announced a major setback this morning in development of its latest diabetes product Degludec. The FDA decided … Continue Reading
Read now- St. Jude (NYSE:STJ) released second quarter earnings this morning, and issued lower sales guidance for its Cardiac Rhythm Segment (CRM), which represents over 50% of … Continue Reading
Read now
